会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY GASTROINTESTINAL DISEASE COMPRISING PATCHOULI EXTRACT
    • 用于预防或治疗包含PATCHOULI提取物的炎症胃肠疾病的药物组合物
    • WO2010147309A3
    • 2011-04-21
    • PCT/KR2010003150
    • 2010-05-19
    • SAMIL PHARMACEUTICAL CO LTDPARK YOUNG-JOONPARK BYUNG-CHULKIM SUN-YEOUKIM JUNG-AE
    • PARK YOUNG-JOONPARK BYUNG-CHULKIM SUN-YEOUKIM JUNG-AE
    • A61K36/53A61K36/428A61P1/00A61P1/04
    • A61K36/53
    • The present invention provides a pharmaceutical composition for preventing or treating inflammatory gastrointestinal disease, and in particular a pharmaceutical composition for preventing or treating ulcerative colitis, Crohn's disease, irritable bowel syndrome or gastritis, which comprises patchouli (Pogostemon cablin) extract as an active ingredient. The patchouli extract has a prophylactic and therapeutic action against ulcerative colitis or Crohn's disease which are commonly known as inflammatory bowel disease, as it effectively suppresses inflammatory bowel disease induced by trinitrobenzene sulfonic acid (TNBS) and also reduces MPO (myeloperoxidase) activity. Further, the patchouli extract not only has a prophylactic and therapeutic action against irritable bowel syndrome because it suppresses contraction of small-intestine and large-intestine circular muscle, but it also has a prophylactic and therapeutic action against gastritis because it has a protective action (cytoprotective action) in damaged gastric mucosa.
    • 本发明提供一种预防或治疗炎性肠胃疾病的药物组合物,特别是用于预防或治疗溃疡性结肠炎,克罗恩病,肠易激综合征或胃炎的药物组合物,其包含广藿香(Pogostemon cablin)提取物作为活性成分。 广藿香提取物具有针对溃疡性结肠炎或克罗恩病的预防和治疗作用,其通常称为炎症性肠病,因为其有效抑制由三硝基苯磺酸(TNBS)诱导的炎症性肠病,并且还降低MPO(髓过氧化物酶)活性。 此外,广藿香提取物不仅具有针对肠易激综合征的预防和治疗作用,因为它抑制小肠和大肠环状肌的收缩,而且由于具有保护作用,因此也具有预防和治疗胃炎的作用 细胞保护作用)在受损的胃粘膜中。